Fervent Synerg.

Who are the top shareholders of the Fervent Synerg.?

The top shareholder of Fervent Synerg is Vijay Thakkar, with a 57.49% stake. Other notable shareholders include Blue Berry Securities Pvt Ltd at 5.66% and individual investors with a combined 8.44%.

The top shareholders of Fervent Synerg include Vijay Thakkar, who holds the largest stake at 57.49%. The company is primarily owned by its promoters, with no pledged promoter holdings reported. The highest public shareholder is Blue Berry Securities Pvt Ltd, which holds 5.66%. Additionally, individual investors collectively own 8.44% of the company. There is also one Foreign Institutional Investor (FII) involved, but they hold a negligible percentage of 0.0%.

how big is Fervent Synerg.?

As of Jun 06, Fervent Synergies Ltd has a market capitalization of 96.00 Cr, with recent net sales of 32.46 Cr and a net profit of 2.96 Cr over the last four quarters. Shareholder's funds are valued at 30.38 Cr, and total assets amount to 30.51 Cr as of Mar'24.

Market Cap: As of Jun 06, Fervent Synergies Ltd has a market capitalization of 96.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest 4 quarters, Fervent Synergies Ltd reported a sum of Net Sales of 32.46 Cr and a sum of Net Profit of 2.96 Cr. This data is based on Standalone financials.<BR><BR>Balance Sheet Snapshot: The Balance Sheet data is Standalone and pertains to the reporting period of Mar'24. Shareholder's Funds are valued at 30.38 Cr, while Total Assets amount to 30.51 Cr.

Has Fervent Synerg. declared dividend?

No Dividend History Available

Who are the peers of the Fervent Synerg.?

Fervent Synerg.'s peers include Redington, MMTC, MSTC, Ravindra Energy, IFL Enterprises, Sharika Enterprises, Amrapali Industries, Le Lavoir, and Ganesha Ecoverse. Key insights show Redington has excellent management risk, IFL Enterprises exhibits strong growth, and Ravindra Energy leads in 1-year returns at 140.95%, while Ganesha Ecoverse has the lowest at -57.41%.

Peers: The peers of Fervent Synerg. are Redington, MMTC, MSTC, Ravindra Energy, IFL Enterprises, Sharika Enterpr., Amrapali Inds., Le Lavoir, and Ganesha Ecoverse.<BR><BR>Quality Snapshot: Excellent management risk is observed at Redington, while Average management risk is found at MMTC and MSTC, and the rest have Below Average management risk. Growth is Excellent at IFL Enterprises, Good at Fervent Synerg., Average at Amrapali Inds., and the rest have Below Average growth. Capital Structure is Excellent at MSTC, Good at Redington and IFL Enterprises, while Fervent Synerg., Amrapali Inds., Sharika Enterpr., and Ganesha Ecoverse have Below Average capital structure, and the rest have Average capital structure.<BR><BR>Return Snapshot: Ravindra Energy has the highest 1-year return at 140.95%, while Ganesha Ecoverse has the lowest at -57.41%, and Fervent Synerg.'s 1-year return of 31.94% is significantly higher than Ganesha Ecoverse's. Additionally, MSTC, IFL Enterprises, Amrapali Inds., Le Lavoir, and Ganesha Ecoverse have negative six-month returns.

What is the technical trend for Fervent Synerg.?

As of May 22, 2025, Fervent Synerg's technical trend is mildly bullish, supported by daily moving averages and a bullish monthly MACD, despite mixed signals from the weekly MACD and Bollinger Bands.

As of 22 May 2025, the technical trend for Fervent Synerg has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD remains bullish, indicating mixed signals. The daily moving averages suggest a mildly bullish stance, contrasting with the weekly Bollinger Bands, which are mildly bearish. The KST shows a bearish trend on the weekly chart but bullish on the monthly. Overall, the lack of clear trends in Dow Theory and the neutral signals from the RSI suggest a cautious outlook. The current technical stance is mildly bullish, driven primarily by the daily moving averages and the monthly MACD.

Who are in the management team of Fervent Synerg.?

As of March 2023, the management team of Fervent Synerg includes Vijay P Thakkar (Chairman/ED & CEO), Karan V Thakkar (Executive Director & CFO), Sanjay P Thakkar (ED/MD/Promoter), and three Independent Non-Executive Directors: Nitin B Parikh, Rajesh M Maheshwari, and Falguni Kaushik Mehta. They oversee the company's operations and strategic direction.

As of March 2023, the management team of Fervent Synerg includes:<BR><BR>1. Vijay P Thakkar - Chairman/ED & CEO<BR>2. Karan V Thakkar - Executive Director & CFO<BR>3. Sanjay P Thakkar - ED / MD / Promoter<BR>4. Nitin B Parikh - Independent Non-Executive Director<BR>5. Rajesh M Maheshwari - Independent Non-Executive Director<BR>6. Falguni Kaushik Mehta - Independent Non-Executive Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

What does Fervent Synerg. do?

Fervent Synergies Ltd, a Micro Cap company in the Trading & Distributors industry, reported net sales of 54 Cr and a net profit of 5 Cr for the quarter ending March 2025. The company, incorporated in 2009, has a market cap of INR 123 Cr and key metrics include a P/E of 46.00 and a return on equity of 8.34%.

Overview:<BR>Fervent Synergies Ltd operates in the Trading & Distributors industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>The company was incorporated in 2009 as Fervent Pharma Synergies Ltd and later changed its name to Fervent Synergies Ltd on July 24, 2012. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 54 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 5 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: INR 123 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 46.00<BR>- Industry P/E: 37<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.00<BR>- Return on Equity: 8.34%<BR>- Price to Book: 3.73<BR><BR>Contact Details:<BR>- Address: B-7/8 Satyam Commercial Comple, M G Road Ghatkopar (East) Mumbai Maharashtra : 400077<BR>- Tel: 91-22-25017801/02/03<BR>- Email: info@ferventsynergies.com<BR>- Website: http://www.ferventsynergies.com

How has been the historical performance of Fervent Synerg.?

Fervent Synerg. has shown significant revenue growth, with net sales increasing from 0.68 Cr in Mar'22 to 32.46 Cr in Mar'25, and a return to profitability with a profit after tax of 2.95 Cr in Mar'25. However, the company still faces negative cash flow from operating activities at -15.00 Cr in Mar'25.

Answer:<BR>The historical performance of Fervent Synerg. shows significant fluctuations in its financial metrics over the years, particularly in net sales and profitability.<BR><BR>Breakdown:<BR>Fervent Synerg. has experienced a notable increase in net sales, rising from 0.68 Cr in Mar'22 to 32.46 Cr in Mar'25, reflecting a strong growth trajectory. Total operating income followed a similar trend, reaching 32.46 Cr in Mar'25 compared to just 0.68 Cr in Mar'22. However, total expenditure peaked at 37.07 Cr in Mar'24 before decreasing to 29.47 Cr in Mar'25, which contributed to an operating profit of 2.99 Cr in Mar'25, a significant recovery from the loss of 12.76 Cr in the previous year. Profit before tax also improved to 2.95 Cr in Mar'25 from a loss of 12.85 Cr in Mar'24, leading to a profit after tax of 2.95 Cr in Mar'25, compared to a loss of 12.84 Cr in Mar'24. The company's equity capital increased to 43.75 Cr in Mar'25 from 30.00 Cr in Mar'24, and total assets rose to 48.78 Cr in Mar'25 from 30.51 Cr in Mar'24. Despite these improvements, the cash flow from operating activities remained negative at -15.00 Cr in Mar'25, indicating challenges in cash generation despite profitability. Overall, while Fervent Synerg. has shown strong revenue growth and a return to profitability, it faces ongoing cash flow issues.

Is Fervent Synerg. overvalued or undervalued?

As of December 2, 2025, Fervent Synerg. is fairly valued with a PE ratio of 25.56 and a PEG ratio of 0.22, making it more attractive compared to peers like Sun Pharma and Divi's Lab, despite recent underperformance against the Sensex.

As of 2 December 2025, Fervent Synerg. has moved from an expensive to a fair valuation grade. The company is currently fairly valued based on its financial metrics, with a PE ratio of 25.56, an EV to EBITDA ratio of 25.36, and a PEG ratio of 0.22. These ratios indicate a more reasonable valuation compared to its peers.<BR><BR>In comparison to its industry peers, Fervent Synerg. stands out with a lower PE ratio than Sun Pharma. Industries, which has a PE of 37.36, and Divi's Lab., which is at 68.62. Additionally, Fervent's PEG ratio of 0.22 is significantly more attractive than that of its competitors, suggesting potential for growth relative to its price. Despite recent underperformance against the Sensex, with a 1-week return of -16.21% compared to the Sensex's 0.65%, the current valuation appears justified given the overall market context.

When is the next results date for Fervent Synergies Ltd?

The next results date for Fervent Synergies Ltd is February 5, 2026.

The next results date for Fervent Synergies Ltd is scheduled for February 5, 2026.

Are Fervent Synergies Ltd latest results good or bad?

Fervent Synergies Ltd's latest results are concerning, showing a significant increase in net profit and operating margin, but stagnant and volatile revenue, leading to a "Strong Sell" rating. The stock has declined 16.03% over the past year, indicating substantial operational challenges.

Fervent Synergies Ltd's latest results indicate a troubling situation overall. While there are some positive signs, such as a significant year-on-year increase in net profit and operating margin, the company's revenue remains alarmingly low and has shown extreme volatility. <BR><BR>In the most recent quarter, net profit was ₹0.43 crores, reflecting a substantial 975% increase year-on-year, and the operating margin improved to 64.71%. However, net sales were stagnant at ₹0.68 crores, which is a drastic decline from ₹26.33 crores reported in December 2024. This inconsistency raises concerns about the sustainability of the company's business model.<BR><BR>The stock has struggled significantly, declining 16.03% over the past year while the Sensex gained 6.49%. Currently, the stock trades at ₹19.49, which is 34.60% below its 52-week high. The company has a low Mojo score of 23 out of 100, indicating a "Strong Sell" rating due to deteriorating fundamentals and unfavorable technical positioning.<BR><BR>Overall, while there are some improvements in profitability metrics, the erratic revenue patterns and lack of scale suggest significant operational challenges. Therefore, the latest results can be characterized as concerning, with multiple red flags indicating a high-risk investment.

Should I buy, sell or hold Fervent Synergies Ltd?

Which are the latest news on Fervent Synerg.?

Why is Fervent Synergies Ltd falling/rising?

As of 10-Feb, Fervent Synergies Ltd's stock price is rising to 19.47, reflecting a 0.36% increase, driven by strong recent performance compared to the Sensex. However, the stock is down 18.02% over the past year, and declining investor participation may pose challenges ahead.

As of 10-Feb, Fervent Synergies Ltd's stock price is rising, currently at 19.47, reflecting a change of 0.07 (0.36%) upward. This increase can be attributed to the stock's strong performance over the past week, where it has outperformed the benchmark Sensex by a significant margin, gaining 7.39% compared to the Sensex's 0.64%. Additionally, the stock has shown positive returns over the past month, with a gain of 7.27%, while the Sensex only increased by 0.83%.<BR><BR>Despite the recent rise, it is important to note that the stock has experienced a decline over the past year, down 18.02%, while the Sensex has risen by 9.01% during the same period. However, the year-to-date performance indicates a recovery trend, with Fervent Synergies Ltd up 3.67% while the Sensex has fallen by 1.11%.<BR><BR>Today's performance also highlights that the stock has outperformed its sector by 0.4%. However, there is a concern regarding falling investor participation, as the delivery volume has decreased by 32.36% against the 5-day average. This decline in participation could impact future price movements. Overall, the current rise in stock price is supported by recent positive performance metrics, despite some underlying challenges.